Comerica Bank’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.73M Sell
27,972
-1,681
-6% -$103K 0.01% 1188
2025
Q3
$1.85M Buy
29,653
+887
+3% +$61.7K 0.01% 1201
2025
Q2
$2.3M Buy
28,766
+1,960
+7% +$164K 0.01% 1055
2025
Q1
$2.3M Sell
26,806
-14,074
-34% -$1.15M 0.01% 1038
2024
Q4
$3.19M Buy
40,880
+100
+0.2% +$7.76K 0.01% 915
2024
Q3
$2.94M Sell
40,780
-994
-2% -$70.4K 0.01% 967
2024
Q2
$2.88M Sell
41,774
-15,901
-28% -$1.08M 0.01% 967
2024
Q1
$4.18M Sell
57,675
-13,518
-19% -$904K 0.02% 816
2023
Q4
$4.36M Buy
71,193
+4,116
+6% +$244K 0.02% 759
2023
Q3
$3.84M Buy
67,077
+1,370
+2% +$82.8K 0.02% 753
2023
Q2
$16 Buy
+65,707
New +$3.93M ﹤0.01% 305
2022
Q4
$5.25M Sell
79,697
-6,538
-8% -$375K 0.04% 537
2022
Q3
$4.56M Sell
86,235
-4,783
-5% -$265K 0.04% 564
2022
Q2
$5.33M Sell
91,018
-2,084
-2% -$115K 0.04% 501
2022
Q1
$5.14M Sell
93,102
-3,455
-4% -$199K 0.04% 576
2021
Q4
$5.45M Sell
96,557
-3,342
-3% -$198K 0.04% 532
2021
Q3
$5.92M Sell
99,899
-1,057
-1% -$58.1K 0.04% 597
2021
Q2
$5.85M Sell
100,956
-28,225
-22% -$1.36M 0.03% 624
2021
Q1
$5.79M Buy
129,181
+26,444
+26% +$1.11M 0.03% 651
2020
Q4
$3.91M Sell
102,737
-738
-0.7% -$26.2K 0.02% 856
2020
Q3
$3.54M Buy
103,475
+2,246
+2% +$83.5K 0.03% 775
2020
Q2
$3.9M Buy
101,229
+314
+0.3% +$12.6K 0.03% 662
2020
Q1
$4.04M Buy
100,915
+5,890
+6% +$229K 0.04% 534
2019
Q4
$3.95M Buy
95,025
+55,367
+140% +$2.07M 0.03% 678
2019
Q3
$1.4M Sell
39,658
-911
-2% -$30K 0.01% 1326
2019
Q2
$1.26M Sell
40,569
-4,768
-11% -$142K 0.01% 1386
2019
Q1
$1.27M Buy
45,337
+198
+0.4% +$5.67K 0.01% 1430
2018
Q4
$1.24M Sell
45,139
-376
-0.8% -$13.7K 0.01% 1414
2018
Q3
$1.69M Sell
45,515
-13,560
-23% -$513K 0.01% 1254
2018
Q2
$2.27M Sell
59,075
-2,359
-4% -$79.5K 0.02% 1180
2018
Q1
$1.89M Sell
61,434
-25,289
-29% -$970K 0.01% 1263
2017
Q4
$3.99M Buy
86,723
+24,046
+38% +$1.1M 0.03% 826
2017
Q3
$2.91M Sell
62,677
-126
-0.2% -$6.44K 0.02% 963
2017
Q2
$3.28M Buy
62,803
+5,075
+9% +$272K 0.02% 852
2017
Q1
$3.34M Buy
57,728
+15,589
+37% +$860K 0.03% 849
2016
Q4
$2.19M Buy
42,139
+5,074
+14% +$245K 0.02% 1132
2016
Q3
$1.79M Buy
37,065
+243
+0.7% +$12.3K 0.02% 1164
2016
Q2
$1.83M Sell
36,822
-17,732
-33% -$977K 0.02% 1125
2016
Q1
$3.08M Buy
54,554
+69
+0.1% +$3.4K 0.03% 729
2015
Q4
$2.57M Buy
54,485
+499
+0.9% +$24.8K 0.03% 806
2015
Q3
$2.44M Sell
53,986
-53,168
-50% -$2.51M 0.02% 873
2015
Q2
$4.95M Buy
107,154
+54,668
+104% +$2.39M 0.02% 942
2015
Q1
$2.25M Sell
52,486
-49,906
-49% -$1.9M 0.02% 1010
2014
Q4
$3.56M Buy
102,392
+49,924
+95% +$1.66M 0.02% 1135
2014
Q3
$1.7M Sell
52,468
-394
-0.7% -$13.2K 0.02% 1173
2014
Q2
$1.79M Sell
52,862
-1,013
-2% -$32.4K 0.02% 1160
2014
Q1
$1.47M Sell
53,875
-1,619
-3% -$48.1K 0.01% 1334
2013
Q4
$1.99M Sell
55,494
-2,789
-5% -$92.6K 0.02% 1123
2013
Q3
$1.75M Sell
58,283
-1,222
-2% -$40K 0.01% 1231
2013
Q2
$1.73M Buy
+59,505
New +$1.68M 0.01% 1047

Other funds holding PBH

Comerica Bank's PBH Position: Q4 2025 in Review

Comerica Bank reduced its Prestige Consumer Healthcare (PBH) stake by 5.7% in Q4 2025, selling an estimated $103K and leaving 27,972 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #1188.

Comerica Bank first reported a position in PBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.92M in Q3 2021. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Comerica Bank held 27,972 shares of Prestige Consumer Healthcare worth $1.73M as of Q4 2025.
  • Comerica Bank sold 1,681 Prestige Consumer Healthcare shares in Q4 2025, an estimated $103K.
  • Prestige Consumer Healthcare made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1188 holding.
  • Comerica Bank first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's Prestige Consumer Healthcare position peaked at $5.92M in Q3 2021.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.